Lee JC - Search Results

1

Discovery of a novel CDK7 inhibitor YPN-005 in small cell lung cancer.

Choi YJ, Lee H, Kim DS, Kim DH, Kang MH, Cho YH, Choi CM, Yoo J, Lee KO, Choi EK, Lee JC, Rho JK. Choi YJ, et al. Among authors: lee ko, lee jc, lee h. Eur J Pharmacol. 2021 Sep 15;907:174298. doi: 10.1016/j.ejphar.2021.174298. Epub 2021 Jul 3. Eur J Pharmacol. 2021. PMID: 34224696

2

p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer.

Rho JK, Choi YJ, Ryoo BY, Na II, Yang SH, Kim CH, Lee JC. Rho JK, et al. Among authors: lee jc. Cancer Res. 2007 Feb 1;67(3):1163-9. doi: 10.1158/0008-5472.CAN-06-2037. Cancer Res. 2007. PMID: 17283151

3

The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.

Na II, Rho JK, Choi YJ, Kim CH, Park JH, Koh JS, Ryoo BY, Yang SH, Lee JC. Na II, et al. Among authors: lee jc. Lung Cancer. 2007 Jul;57(1):96-102. doi: 10.1016/j.lungcan.2007.01.027. Epub 2007 Mar 6. Lung Cancer. 2007. PMID: 17337084

4

Choroidal metastasis of small cell lung cancer.

Lim HH, Choi SY, Yoo HJ, Kim CH, Lee JC. Lim HH, et al. Among authors: lee jc. J Thorac Oncol. 2006 Sep;1(7):714-5. J Thorac Oncol. 2006. PMID: 17409942 Free article. No abstract available.

5

Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer.

Na II, Rho JK, Choi YJ, Kim CH, Koh JS, Ryoo BY, Yang SH, Lee JC. Na II, et al. Among authors: lee jc. J Korean Med Sci. 2007 Jun;22(3):393-9. doi: 10.3346/jkms.2007.22.3.393. J Korean Med Sci. 2007. PMID: 17596643 Free PMC article.

6

Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line.

Rho JK, Choi YJ, Lee JK, Ryoo BY, Na II, Yang SH, Kim CH, Lee JC. Rho JK, et al. Among authors: lee jc, lee jk. Lung Cancer. 2009 Feb;63(2):219-26. doi: 10.1016/j.lungcan.2008.05.017. Epub 2008 Jul 2. Lung Cancer. 2009. PMID: 18599154

7

HIF-1alpha modulation by topoisomerase inhibitors in non-small cell lung cancer cell lines.

Choi YJ, Rho JK, Lee SJ, Jang WS, Lee SS, Kim CH, Lee JC. Choi YJ, et al. Among authors: lee sj, lee jc, lee ss. J Cancer Res Clin Oncol. 2009 Aug;135(8):1047-53. doi: 10.1007/s00432-009-0543-2. Epub 2009 Jan 15. J Cancer Res Clin Oncol. 2009. PMID: 19148680

8

Treatment of stage I non-small cell lung cancer with CyberKnife, image-guided robotic stereotactic radiosurgery.

Ahn SH, Han MS, Yoon JH, Jeon SY, Kim CH, Yoo HJ, Lee JC. Ahn SH, et al. Among authors: lee jc. Oncol Rep. 2009 Mar;21(3):693-6. Oncol Rep. 2009. PMID: 19212628

9

Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1alpha.

Rho JK, Choi YJ, Lee JK, Ryoo BY, Na II, Yang SH, Kim CH, Yoo YD, Lee JC. Rho JK, et al. Among authors: lee jc, lee jk. Oncol Rep. 2009 Mar;21(3):801-7. Oncol Rep. 2009. PMID: 19212642

10

The role of MET activation in determining the sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors.

Rho JK, Choi YJ, Lee JK, Ryoo BY, Na II, Yang SH, Lee SS, Kim CH, Yoo YD, Lee JC. Rho JK, et al. Among authors: lee jc, lee jk, lee ss. Mol Cancer Res. 2009 Oct;7(10):1736-43. doi: 10.1158/1541-7786.MCR-08-0504. Epub 2009 Oct 6. Mol Cancer Res. 2009. PMID: 19808904

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,850 results

Search Page